Sarepta Therapeutics Inc
NASDAQ: SRPT
$119.02
+$4.94 (+4.3%)
Closing Price on February 5, 2025
SRPT Articles
La Jolla Pharmaceutical and Sarepta Therapeutics are among seven biotech stocks that have seen some notable insider trading recently.
Published:
Last Updated:
The include top analyst upgrades, downgrades and other research calls from Wednesday Akamai Technologies, Apple, AutoZone, Dropbox, Electronic Arts, Ford, Kinder Morgan, Pandora Media, Procter &...
Published:
Last Updated:
Sarepta Therapeutics shares skyrocketed on Tuesday after the firm presented positive preliminary results from its midstage Duchenne muscular dystrophy trial.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday included AMC, Alkermes, Echostar, Kohls, L Brands, US Bancorp and Sarepta Therapeutics.
Published:
Last Updated:
These four top Suntrust biotech picks for 2018 all have the potential for big upside moves if they do indeed exceed first-quarter expectations.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include AMD, Altice, Century Aluminum, Cerner, Chipotle, Cigna, GE, Micron and Noble Energy.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include BioMarin, CSX, Kinder Morgan, Microsemi, Splunk, U.S. Steel and Walmart.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Callaway Golf, Capital One, Sarepta Therapeutics, Tesla, UnitedHealth and Wayfair.
Published:
Last Updated:
A new RBC report is reasonably positive on the biotech sector for the coming year. These eight top picks for 2018 all have the potential for big upside moves.
Published:
Sarepta Therapeutics saw its shares hit a new multiyear high on Friday after the firm announced that it received a key approval from the FDA.
Published:
Last Updated:
Amicus Therapeutics is another biotech player seeing a nice boost from the World Muscle Society Conference in France.
Published:
Last Updated:
Catabasis Pharmaceuticals shares continued their incredible climb after the announcement of positive efficacy results from its MoveDMD trial in a late-breaking session at the World Muscle Society...
Published:
Last Updated:
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) saw its shares make a handy gain on Monday after the firm received an upgrade from Morgan Stanley. The driving force behind this upgrade is Sarepta’s...
Published:
Last Updated:
courtesy of Jon OggStocks were indicated to open higher on Monday after hitting all-time highs the prior week. The one trend that has been proven time after time in this eight-year bull market is...
Published:
Last Updated:
24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.